Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxagliptin vs Acarbose in T2D Inadequately Controlled with Metformin
NCT02243176Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2014
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of saxagliptin in type 2 diabetes mellitus (T2DM), sponsored by AstraZeneca. Started Sep 2014; status: completed.
02
Drugs
saxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02243176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02243176.